Skip to Main Content

The (POGO) Blog

February 28, 2014

By Avery Kleinman

FDA Surveillance Threatened Whistleblowers



Angela's FDA Testimony On Wednesday, POGO's Angela Canterbury testified in front of the House Oversight and Government Reform committee on the wrongful surveillance of whistleblowers at the FDA.

Continue Reading FDA Surveillance Threatened Whistleblowers

Topics: Whistleblower Protections

February 12, 2013

By Andre Francisco

POGO's Staff Scientist Says New Doctor Rules Promote Transparency



Drug and FDA Issues New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, POGO's staff scientist.

Continue Reading POGO's Staff Scientist Says New Doctor Rules Promote Transparency

Topics: Public Health and Science

February 4, 2013

By Andre Francisco

Government to Require Greater Doctor Payment Transparency



Drug and FDA Issues The federal government announced it would require drug and medical device makers to publicly disclose their payments to doctors and hospitals.

Continue Reading Government to Require Greater Doctor Payment Transparency

Topics: Public Health and Science

Browse POGOBlog by Topic

POGO on Facebook

Latest Podcast

Podcast: Exploring Transparency for Oil and Gas Extraction

Mia Steinle talks about POGO's involvement in the Extractive Industries Transparency Initiative (EITI) and the hurdles to increased transparency for oil, gas and hard rock minerals here in the U.S.